Evidence-Based Care in Atopic Dermatitis: Practical Considerations for IL-13 Inhibitors for Moderate to Severe Disease
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Evidence-Based Care in Atopic Dermatitis: Practical Considerations for IL-13 Inhibitors for Moderate to Severe Disease
-
Narrated by:
-
By:
About this listen
In this episode, Daniel C. Butler, MD, and Shawn G. Kwatra, MD, discuss the practical considerations for using IL-13 inhibitors to treat patients with moderate to severe atopic dermatitis, including:
- Patient candidacy considerations
- Treatment advancement strategies that go beyond topical therapies
- The importance of patient-centered care that address patients’ fears and needs
- A detailed patient case to highlight take home points
Presenter
Daniel C. Butler, MD
Assistant Dean Student Affairs
University of Arizona College of Medicine – Tucson
Tucson, Arizona
Shawn G. Kwatra, MD
Dr. Joseph W. Burnett Endowed Professor and Chair
Department of Dermatology
University of Maryland School of Medicine
Baltimore, Maryland
Program page:
https://bit.ly/4kTP04D
No reviews yet